Pomalidomide-PEG3-NH2 hydrochloride

Background Introduction

Pomalidomide-PEG3-NH2 hydrochloride is a versatile E3 ligase ligand-linker conjugate primarily used in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound incorporates pomalidomide, an immunomodulatory agent well-known for binding to cereblon (CRBN), an E3 ubiquitin ligase. With a PEG3 (triethylene glycol) linker and an amine (NH2) functional group, Pomalidomide-PEG3-NH2 hydrochloride provides a flexible and hydrophilic scaffold for PROTAC design and customization.

Mechanism

Pomalidomide-PEG3-NH2 hydrochloride functions by recruiting the CRBN E3 ubiquitin ligase complex upon incorporation into a PROTAC molecule. The pomalidomide moiety specifically and effectively binds to the CRBN substrate recognition domain. The PEG3 linker offers enhanced solubility and spatial flexibility, aiding the bifunctional PROTAC in simultaneously binding the target protein and the E3 ligase. This proximity promotes ubiquitination and subsequent proteasomal degradation of the target protein, leading to its efficient downregulation within cells.

Applications

Pomalidomide-PEG3-NH2 hydrochloride is widely utilized in the rational design and synthesis of PROTAC molecules for targeted protein degradation research. Its applications include developing custom PROTACs for studies in oncology, neurodegeneration, and other disease models where protein degradation is a therapeutic strategy. The amine functional group enables straightforward conjugation with various target protein ligands via amide coupling or other chemistries, making this conjugate a valuable building block in academic, pharmaceutical, and biotech research environments focused on chemical biology and drug discovery.

Pomalidomide-PEG3-NH2 hydrochloride serves as a versatile E3 Ligase Ligand-Linker Conjugate in PROTACs, enhancing targeted protein degradation by linking E3 ligase to target proteins. The following provides a detailed description of this molecule, focusing on its linker, ligand, and ideal target protein ligands.

Linker: The linker in this molecule is a PEG3 (polyethylene glycol) chain, providing moderate length and flexibility, which facilitates optimal spatial arrangement between the ligand and the target protein. It is non-cleavable, ensuring stable conjugation and sustained interaction throughout the degradation process.

Ligand: The ligand component is derived from pomalidomide, a thalidomide analog known for its high affinity binding to the cereblon E3 ligase. Its structural characteristics allow for efficient recruitment of the ligase, promoting effective ubiquitination and subsequent proteasomal degradation of target proteins.

Reactive Site: The reactive site in this molecule is the terminal amine group, which is suitable for coupling with various target protein ligands. Recommended reaction types include amide bond formation or reductive amination, facilitating robust and stable conjugation under mild conditions.

Recommended Target Protein Ligand: The recommended warhead for this molecule is a small molecule inhibitor or modulator with a reactive functional group, such as a carboxylic acid or aldehyde. These warheads are advantageous due to their ability to form stable covalent bonds with the reactive site, enabling precise and efficient degradation of target proteins in experimental studies.